Judge OKs $385million antitrust settlement over Suboxone plot

A federal judge approved a $385million settlement between a group of direct purchasers and Indivior Inc over claims the drugmaker abused its monopoly over the Suboxone opioid addiction treatment. He also approved $120.6million in attorney fees.